Dr. Peter Rubin
Claim this profileMaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford
Studies Breast Cancer
Studies Lung Cancer
17 reported clinical trials
42 drugs studied
Area of expertise
1Breast Cancer
Stage IV
Stage III
Stage II
2Lung Cancer
Stage II
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Peter Rubin is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
More about Peter Rubin
Clinical Trial Related5 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Peter Rubin has experience with
- Atezolizumab
- Paclitaxel
- Pembrolizumab
- Gemcitabine Hydrochloride
- Carboplatin
- Pemetrexed Disodium
Breakdown of trials Peter Rubin has run
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Colon Cancer
Relapse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Peter Rubin specialize in?
Is Peter Rubin currently recruiting for clinical trials?
Are there any treatments that Peter Rubin has studied deeply?
What is the best way to schedule an appointment with Peter Rubin?
What is the office address of Peter Rubin?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.